CONMED Corporation (CNMD)
USD 55.43
(-1.44%)
USD 55.43
(-1.44%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 2.3 Billion USD | 0.11% |
| 2022 | 2.29 Billion USD | 30.1% |
| 2021 | 1.76 Billion USD | 0.82% |
| 2020 | 1.75 Billion USD | -1.32% |
| 2019 | 1.77 Billion USD | 29.65% |
| 2018 | 1.36 Billion USD | 0.82% |
| 2017 | 1.35 Billion USD | 2.18% |
| 2016 | 1.32 Billion USD | 19.41% |
| 2015 | 1.11 Billion USD | 1.34% |
| 2014 | 1.09 Billion USD | 0.7% |
| 2013 | 1.09 Billion USD | 0.56% |
| 2012 | 1.08 Billion USD | 15.91% |
| 2011 | 935.59 Million USD | -5.09% |
| 2010 | 985.77 Million USD | 2.95% |
| 2009 | 957.5 Million USD | 2.77% |
| 2008 | 931.66 Million USD | 4.22% |
| 2007 | 893.95 Million USD | 3.76% |
| 2006 | 861.57 Million USD | -4.67% |
| 2005 | 903.78 Million USD | 3.55% |
| 2004 | 872.82 Million USD | 8.42% |
| 2003 | 805.05 Million USD | 8.48% |
| 2002 | 742.14 Million USD | 5.78% |
| 2001 | 701.6 Million USD | 3.24% |
| 2000 | 679.57 Million USD | 2.62% |
| 1999 | 662.2 Million USD | 5.31% |
| 1998 | 628.8 Million USD | 11.97% |
| 1997 | 561.6 Million USD | 230.16% |
| 1996 | 170.1 Million USD | 42.46% |
| 1995 | 119.4 Million USD | 92.27% |
| 1994 | 62.1 Million USD | 8.38% |
| 1993 | 57.3 Million USD | 36.75% |
| 1992 | 41.9 Million USD | 9.4% |
| 1991 | 38.3 Million USD | 72.52% |
| 1990 | 22.2 Million USD | 1.37% |
| 1989 | 21.9 Million USD | 62.22% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 2.28 Billion USD | -1.02% |
| 2024 Q3 | 2.31 Billion USD | 1.32% |
| 2024 Q1 | 2.3 Billion USD | 0.4% |
| 2023 Q2 | 2.32 Billion USD | 0.11% |
| 2023 Q1 | 2.32 Billion USD | 0.98% |
| 2023 Q3 | 2.32 Billion USD | 0.13% |
| 2023 Q4 | 2.3 Billion USD | -1.1% |
| 2023 FY | 2.3 Billion USD | 0.11% |
| 2022 Q3 | 2.29 Billion USD | 10.61% |
| 2022 FY | 2.29 Billion USD | 30.1% |
| 2022 Q2 | 2.07 Billion USD | 16.05% |
| 2022 Q4 | 2.29 Billion USD | 0.24% |
| 2022 Q1 | 1.78 Billion USD | 1.12% |
| 2021 Q3 | 1.75 Billion USD | -0.45% |
| 2021 FY | 1.76 Billion USD | 0.82% |
| 2021 Q1 | 1.74 Billion USD | -0.29% |
| 2021 Q2 | 1.76 Billion USD | 0.88% |
| 2021 Q4 | 1.76 Billion USD | 0.68% |
| 2020 Q4 | 1.75 Billion USD | 0.49% |
| 2020 FY | 1.75 Billion USD | -1.32% |
| 2020 Q3 | 1.74 Billion USD | 1.11% |
| 2020 Q2 | 1.72 Billion USD | -1.55% |
| 2020 Q1 | 1.75 Billion USD | -1.36% |
| 2019 FY | 1.77 Billion USD | 29.65% |
| 2019 Q3 | 1.75 Billion USD | -0.06% |
| 2019 Q4 | 1.77 Billion USD | 0.95% |
| 2019 Q2 | 1.75 Billion USD | -0.08% |
| 2019 Q1 | 1.76 Billion USD | 28.61% |
| 2018 Q3 | 1.36 Billion USD | -0.06% |
| 2018 FY | 1.36 Billion USD | 0.82% |
| 2018 Q1 | 1.35 Billion USD | -0.58% |
| 2018 Q2 | 1.36 Billion USD | 1.01% |
| 2018 Q4 | 1.36 Billion USD | 0.45% |
| 2017 Q4 | 1.35 Billion USD | -0.24% |
| 2017 Q2 | 1.33 Billion USD | 0.55% |
| 2017 Q1 | 1.32 Billion USD | -0.07% |
| 2017 Q3 | 1.36 Billion USD | 1.94% |
| 2017 FY | 1.35 Billion USD | 2.18% |
| 2016 Q1 | 1.34 Billion USD | 20.65% |
| 2016 Q3 | 1.33 Billion USD | -0.61% |
| 2016 Q2 | 1.33 Billion USD | -0.29% |
| 2016 FY | 1.32 Billion USD | 19.41% |
| 2016 Q4 | 1.32 Billion USD | -0.13% |
| 2015 Q2 | 1.08 Billion USD | 0.15% |
| 2015 FY | 1.11 Billion USD | 1.34% |
| 2015 Q1 | 1.08 Billion USD | -0.95% |
| 2015 Q4 | 1.11 Billion USD | 1.73% |
| 2015 Q3 | 1.09 Billion USD | 0.43% |
| 2014 FY | 1.09 Billion USD | 0.7% |
| 2014 Q4 | 1.09 Billion USD | -1.02% |
| 2014 Q1 | 1.08 Billion USD | -0.67% |
| 2014 Q2 | 1.09 Billion USD | 1.3% |
| 2014 Q3 | 1.1 Billion USD | 1.11% |
| 2013 Q3 | 1.08 Billion USD | 0.08% |
| 2013 Q4 | 1.09 Billion USD | 0.61% |
| 2013 Q2 | 1.08 Billion USD | 0.0% |
| 2013 Q1 | 1.08 Billion USD | -0.14% |
| 2013 FY | 1.09 Billion USD | 0.56% |
| 2012 Q4 | 1.08 Billion USD | -0.4% |
| 2012 FY | 1.08 Billion USD | 15.91% |
| 2012 Q2 | 1.06 Billion USD | -1.42% |
| 2012 Q1 | 1.07 Billion USD | 15.07% |
| 2012 Q3 | 1.08 Billion USD | 2.6% |
| 2011 Q3 | 999.19 Million USD | -0.1% |
| 2011 Q1 | 992.4 Million USD | 0.67% |
| 2011 Q2 | 1 Billion USD | 0.78% |
| 2011 Q4 | 935.59 Million USD | -6.36% |
| 2011 FY | 935.59 Million USD | -5.09% |
| 2010 Q2 | 986.74 Million USD | -0.57% |
| 2010 Q4 | 985.77 Million USD | -1.7% |
| 2010 Q1 | 992.36 Million USD | 3.54% |
| 2010 Q3 | 1 Billion USD | 1.63% |
| 2010 FY | 985.77 Million USD | 2.95% |
| 2009 FY | 957.5 Million USD | 2.77% |
| 2009 Q3 | 951.48 Million USD | 2.19% |
| 2009 Q4 | 958.41 Million USD | 0.73% |
| 2009 Q2 | 931.04 Million USD | 0.35% |
| 2009 Q1 | 927.81 Million USD | -0.41% |
| 2008 Q4 | 931.66 Million USD | -1.9% |
| 2008 Q3 | 949.72 Million USD | 1.25% |
| 2008 Q2 | 938.04 Million USD | 1.43% |
| 2008 FY | 931.66 Million USD | 4.22% |
| 2008 Q1 | 924.85 Million USD | 3.46% |
| 2007 Q4 | 893.95 Million USD | 0.21% |
| 2007 FY | 893.95 Million USD | 3.76% |
| 2007 Q1 | 875.28 Million USD | 1.59% |
| 2007 Q2 | 875.11 Million USD | -0.02% |
| 2007 Q3 | 892.07 Million USD | 1.94% |
| 2006 Q2 | 907.57 Million USD | 0.06% |
| 2006 Q3 | 919.8 Million USD | 1.35% |
| 2006 Q4 | 861.57 Million USD | -6.33% |
| 2006 FY | 861.57 Million USD | -4.67% |
| 2006 Q1 | 907.06 Million USD | 0.36% |
| 2005 Q2 | 891.8 Million USD | 1.33% |
| 2005 FY | 903.78 Million USD | 3.55% |
| 2005 Q4 | 903.78 Million USD | 0.21% |
| 2005 Q1 | 880.12 Million USD | 0.84% |
| 2005 Q3 | 901.91 Million USD | 1.13% |
| 2004 FY | 872.82 Million USD | 8.42% |
| 2004 Q1 | 800.63 Million USD | -0.55% |
| 2004 Q2 | 812.36 Million USD | 1.47% |
| 2004 Q3 | 865.47 Million USD | 6.54% |
| 2004 Q4 | 872.82 Million USD | 0.85% |
| 2003 FY | 805.05 Million USD | 8.48% |
| 2003 Q2 | 794.42 Million USD | 0.15% |
| 2003 Q1 | 793.23 Million USD | 6.88% |
| 2003 Q4 | 805.05 Million USD | 0.45% |
| 2003 Q3 | 801.48 Million USD | 0.89% |
| 2002 Q4 | 742.14 Million USD | 2.97% |
| 2002 Q1 | 706.95 Million USD | 0.76% |
| 2002 FY | 742.14 Million USD | 5.78% |
| 2002 Q2 | 717.91 Million USD | 1.55% |
| 2002 Q3 | 720.76 Million USD | 0.4% |
| 2001 FY | 701.6 Million USD | 3.24% |
| 2001 Q4 | 701.6 Million USD | -5.1% |
| 2001 Q3 | 739.34 Million USD | 8.35% |
| 2001 Q2 | 682.36 Million USD | 0.19% |
| 2001 Q1 | 681.09 Million USD | 0.22% |
| 2000 FY | 679.57 Million USD | 2.62% |
| 2000 Q2 | 669.62 Million USD | 0.7% |
| 2000 Q3 | 675.91 Million USD | 0.94% |
| 2000 Q4 | 679.57 Million USD | 0.54% |
| 2000 Q1 | 664.94 Million USD | 0.41% |
| 1999 Q2 | 628.4 Million USD | 0.0% |
| 1999 Q3 | 662.1 Million USD | 5.36% |
| 1999 Q4 | 662.2 Million USD | 0.02% |
| 1999 FY | 662.2 Million USD | 5.31% |
| 1999 Q1 | 628.4 Million USD | -0.06% |
| 1998 Q3 | 583.9 Million USD | 2.31% |
| 1998 Q4 | 628.8 Million USD | 7.69% |
| 1998 FY | 628.8 Million USD | 11.97% |
| 1998 Q1 | 569.1 Million USD | 1.34% |
| 1998 Q2 | 570.7 Million USD | 0.28% |
| 1997 Q4 | 561.6 Million USD | 205.55% |
| 1997 FY | 561.6 Million USD | 230.16% |
| 1997 Q1 | 176.5 Million USD | 3.76% |
| 1997 Q2 | 179.1 Million USD | 1.47% |
| 1997 Q3 | 183.8 Million USD | 2.62% |
| 1996 FY | 170.1 Million USD | 42.46% |
| 1996 Q1 | 162.6 Million USD | 36.18% |
| 1996 Q2 | 162.5 Million USD | -0.06% |
| 1996 Q3 | 165 Million USD | 1.54% |
| 1996 Q4 | 170.1 Million USD | 3.09% |
| 1995 FY | 119.4 Million USD | 92.27% |
| 1995 Q2 | 116.2 Million USD | 13.48% |
| 1995 Q3 | 118.1 Million USD | 1.64% |
| 1995 Q4 | 119.4 Million USD | 1.1% |
| 1995 Q1 | 102.4 Million USD | 64.9% |
| 1994 Q4 | 62.1 Million USD | 2.99% |
| 1994 Q1 | 58.8 Million USD | 2.62% |
| 1994 Q2 | 58.5 Million USD | -0.51% |
| 1994 Q3 | 60.3 Million USD | 3.08% |
| 1994 FY | 62.1 Million USD | 8.38% |
| 1993 Q4 | 57.3 Million USD | -0.35% |
| 1993 Q3 | 57.5 Million USD | 35.29% |
| 1993 Q1 | 42.3 Million USD | 0.95% |
| 1993 FY | 57.3 Million USD | 36.75% |
| 1993 Q2 | 42.5 Million USD | 0.47% |
| 1992 Q2 | 41.1 Million USD | 3.53% |
| 1992 Q4 | 41.9 Million USD | -2.56% |
| 1992 Q1 | 39.7 Million USD | 3.66% |
| 1992 FY | 41.9 Million USD | 9.4% |
| 1992 Q3 | 43 Million USD | 4.62% |
| 1991 Q2 | 34.2 Million USD | 34.65% |
| 1991 Q3 | 36.5 Million USD | 6.73% |
| 1991 FY | 38.3 Million USD | 72.52% |
| 1991 Q4 | 38.3 Million USD | 4.93% |
| 1991 Q1 | 25.4 Million USD | 14.41% |
| 1990 Q3 | 22.9 Million USD | -2.14% |
| 1990 Q1 | 23 Million USD | 5.02% |
| 1990 Q4 | 22.2 Million USD | -3.06% |
| 1990 FY | 22.2 Million USD | 1.37% |
| 1990 Q2 | 23.4 Million USD | 1.74% |
| 1989 Q3 | 20.7 Million USD | 0.0% |
| 1989 Q4 | 21.9 Million USD | 5.8% |
| 1989 FY | 21.9 Million USD | 62.22% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Abbott Laboratories | 73.21 Billion USD | 96.858% |
| Allurion Technologies Inc. | 71.71 Million USD | -3107.303% |
| Artivion, Inc. | 792.39 Million USD | -190.261% |
| Avanos Medical, Inc. | 1.69 Billion USD | -35.903% |
| Butterfly Network, Inc. | 304.27 Million USD | -655.905% |
| Butterfly Network, Inc. | 304.27 Million USD | -655.905% |
| Bio-Rad Laboratories, Inc. | 12.29 Billion USD | 81.299% |
| Boston Scientific Corporation | 35.13 Billion USD | 93.454% |
| Edwards Lifesciences Corporation | 9.36 Billion USD | 75.436% |
| Paragon 28, Inc. | 340.69 Million USD | -575.089% |
| Glaukos Corporation | 940.41 Million USD | -144.575% |
| Globus Medical, Inc. | 5.08 Billion USD | 54.778% |
| Inspire Medical Systems, Inc. | 676.81 Million USD | -239.832% |
| Integer Holdings Corporation | 2.94 Billion USD | 21.839% |
| Medtronic plc | 89.98 Billion USD | 97.444% |
| Myomo, Inc. | 14.58 Million USD | -15673.482% |
| Nevro Corp. | 635.71 Million USD | -261.802% |
| Owlet, Inc. | 44.12 Million USD | -5112.748% |
| Penumbra, Inc. | 1.55 Billion USD | -47.787% |
| Vicarious Surgical Inc. | 119.86 Million USD | -1818.859% |
| Smith & Nephew plc | 9.98 Billion USD | 76.97% |
| Sonendo, Inc. | 78.16 Million USD | -2842.709% |
| STERIS plc | 11.06 Billion USD | 79.211% |
| Stryker Corporation | 39.91 Billion USD | 94.237% |
| Vapotherm, Inc. | 77.61 Million USD | -2863.295% |
| Zimmer Biomet Holdings, Inc. | 21.49 Billion USD | 89.301% |